Daniel Bachman1, John Nyland1, Ryan Krupp1. 1. Daniel Bachman, John Nyland, Ryan Krupp, Department of Orthopaedic Surgery, University of Louisville, Louisville, KY 40202, United States.
Abstract
AIM: To compare reverse-total shoulder arthroplasty (RSA) cost-effectiveness with total hip arthroplasty cost-effectiveness. METHODS: This study used a stochastic model and decision-making algorithm to compare the cost-effectiveness of RSA and total hip arthroplasty. Fifteen patients underwent pre-operative, and 3, 6, and 12 mo post-operative clinical examinations and Short Form-36 Health Survey completion. Short form-36 Health Survey subscale scores were converted to EuroQual Group Five Dimension Health Outcome scores and compared with historical data from age-matched patients who had undergone total hip arthroplasty. Quality-adjusted life year (QALY) improvements based on life expectancies were calculated. RESULTS: The cost/QALY was $3900 for total hip arthroplasty and $11100 for RSA. After adjusting the model to only include shoulder-specific physical function subscale items, the RSA QALY improved to 2.8 years, and its cost/QALY decreased to $8100. CONCLUSION: Based on industry accepted standards, cost/QALY estimates supported both RSA and total hip arthroplasty cost-effectiveness. Although total hip arthroplasty remains the quality of life improvement "gold standard" among arthroplasty procedures, cost/QALY estimates identified in this study support the growing use of RSA to improve patient quality of life.
AIM: To compare reverse-total shoulder arthroplasty (RSA) cost-effectiveness with total hip arthroplasty cost-effectiveness. METHODS: This study used a stochastic model and decision-making algorithm to compare the cost-effectiveness of RSA and total hip arthroplasty. Fifteen patients underwent pre-operative, and 3, 6, and 12 mo post-operative clinical examinations and Short Form-36 Health Survey completion. Short form-36 Health Survey subscale scores were converted to EuroQual Group Five Dimension Health Outcome scores and compared with historical data from age-matched patients who had undergone total hip arthroplasty. Quality-adjusted life year (QALY) improvements based on life expectancies were calculated. RESULTS: The cost/QALY was $3900 for total hip arthroplasty and $11100 for RSA. After adjusting the model to only include shoulder-specific physical function subscale items, the RSA QALY improved to 2.8 years, and its cost/QALY decreased to $8100. CONCLUSION: Based on industry accepted standards, cost/QALY estimates supported both RSA and total hip arthroplasty cost-effectiveness. Although total hip arthroplasty remains the quality of life improvement "gold standard" among arthroplasty procedures, cost/QALY estimates identified in this study support the growing use of RSA to improve patient quality of life.
Entities:
Keywords:
Arthroplasty; Cost-analysis; Quality of life; Shoulder
Authors: L M March; M J Cross; H Lapsley; A J Brnabic; K L Tribe; C J Bachmeier; B G Courtenay; P M Brooks Journal: Med J Aust Date: 1999-09-06 Impact factor: 7.738
Authors: C M Mangione; L Goldman; E J Orav; E R Marcantonio; A Pedan; L E Ludwig; M C Donaldson; D J Sugarbaker; R Poss; T H Lee Journal: J Gen Intern Med Date: 1997-11 Impact factor: 5.128
Authors: Pascal Boileau; Barbara Melis; David Duperron; Grégory Moineau; Adam P Rumian; Yung Han Journal: J Shoulder Elbow Surg Date: 2013-05-22 Impact factor: 3.019
Authors: Stephen G Thon; Adam J Seidl; Jonathan T Bravman; Eric C McCarty; Felix H Savoie; Rachel M Frank Journal: Curr Rev Musculoskelet Med Date: 2020-02
Authors: Alexandre Lädermann; Patrick Joel Denard; Jérome Tirefort; Philippe Collin; Alexandra Nowak; Adrien Jean-Pierre Schwitzguebel Journal: J Orthop Surg Res Date: 2017-07-14 Impact factor: 2.359
Authors: Kevin X Farley; Jacob M Wilson; Anjali Kumar; Michael B Gottschalk; Charles Daly; Joaquin Sanchez-Sotelo; Eric R Wagner Journal: JB JS Open Access Date: 2021-07-14